NCT02668159View on ClinicalTrials.gov

Pilot Study on Metabolic Effects of Fish Peptides and Vitamin D

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2017

Conditions
PrediabetesInsulin Resistance
Interventions
DIETARY_SUPPLEMENT

Fish peptide supplement

6 capsules of fish peptide supplement (3g/each) administered prior to one of the OGTT

DIETARY_SUPPLEMENT

Vitamin D supplement

1 tablet of vitamin D3 (1000 UI) administered prior to one of the OGTT

DIETARY_SUPPLEMENT

Fish peptide + Vitamin D3 supplements

6 capsules of fish peptide (3g/each) + 1 tablet of vitamin D3 (1000 UI) administered prior to one of the OGTT

DIETARY_SUPPLEMENT

Placebo

7 tablets of placebos administered prior to one the OGTT

Trial Locations (1)

G1V 0A6

Institute of Nutrition and Functional Foods (INAF), Laval University, Québec

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Laval University

OTHER

NCT02668159 - Pilot Study on Metabolic Effects of Fish Peptides and Vitamin D | Biotech Hunter | Biotech Hunter